CK0804
Showing 1 - 18 of 18
Myelofibrosis Trial in Houston (CK0804)
Not yet recruiting
- Myelofibrosis
- CK0804
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jun 28, 2022
NSCLC Trial in Worldwide (MEDI4736, PLACEBO)
Active, not recruiting
- Non-Small Cell Lung Cancer
- MEDI4736
- PLACEBO
-
Chandler, Arizona
- +235 more
Jan 4, 2023
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)
Recruiting
- Clear Cell Renal Cell Carcinoma
- Belzutifan
- +2 more
-
Duarte, California
- +250 more
Jan 27, 2023
XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post
Completed
- Ischemic Heart Disease
- +4 more
- XIENCE PRIME SV Everolimus Eluting Coronary Stent
-
Chiba, Japan
- +32 more
Apr 12, 2021
Perioperative/Postoperative Complications Trial in München
Active, not recruiting
- Perioperative/Postoperative Complications
-
München, Bavaria, GermanyKlinikum Rechts der Isar, Technische Universität München
Jul 31, 2020
Atherosclerotic Cardiovascular Disease Trial in Worldwide (Lp(a) Screening)
Recruiting
- Atherosclerotic Cardiovascular Disease
- Lp(a) Screening
-
Birmingham, Alabama
- +670 more
Feb 1, 2023
Diabetic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Completed
- Diabetic Kidney Disease
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +974 more
Apr 13, 2022
Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab
Terminated
- Small Cell Lung Cancer
- Placebo for dexamethasone
- +3 more
-
Huntsville, Alabama
- +307 more
Jul 28, 2021
Prevention of Stroke or Systemic Embolism, Atrial Fibrillation Trial in Worldwide (Asundexian (BAY2433334), Apixaban, Asundexian
Recruiting
- Prevention of Stroke or Systemic Embolism
- Atrial Fibrillation
- Asundexian (BAY2433334)
- +3 more
-
Dothan, Alabama
- +1128 more
Jan 5, 2023
Chronic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Completed
- Chronic Kidney Disease
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +977 more
Jun 29, 2021
Hepatobiliary Disorders, Non-alcoholic Steatohepatitis Trial in Worldwide (Semaglutide, Placebo)
Completed
- Hepatobiliary Disorders
- Non-alcoholic Steatohepatitis
- Semaglutide
- Placebo
-
Birmingham, Alabama
- +157 more
Nov 15, 2021
Moderate to Very Severe COPD Trial in Worldwide (Benralizumab Arm A, Benralizumab Arm B, Placebo)
Completed
- Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Benralizumab Arm A
- +2 more
-
Andalusia, Alabama
- +408 more
Jun 12, 2019
Opioid-use Disorder, Pain, Acute, Surgery Trial (buprenorphine/naloxone)
Unknown status
- Opioid-use Disorder
- +2 more
- (no location specified)
Oct 5, 2018
Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )
Completed
- Diabetes Mellitus, Type 2
- Ticagrelor 60 mg
- Ticagrelor placebo
-
Alexander City, Alabama
- +1241 more
Mar 4, 2020